About Surgical & Medical Robots
The Surgical & Medical Robots category is part of the Special Purpose Robotics market map, tracking 15 companies building in this segment. Surgical robots, warehouse automation, agricultural bots, inspection drones, and industrial manipulators solving domain-specific physical tasks. Curated by Hartmann Capital's venture research team.
Companies in Surgical & Medical Robots
- Intuitive Surgical — Public
- Medtronic (Hugo) — Public
- Stryker (Mako) — Public
- Zimmer Biomet (ROSA) — Public
- CMR Surgical — Series D, $1B
- Noah Medical — Series B, $150M
- PROCEPT BioRobotics — Public, $349M
- THINK Surgical — Series D, $253M
- Vicarious Surgical — Public, $43M
- ForSight Robotics — Series B, $195M
- EndoQuest Robotics — Series D, $126M
- Globus Medical — Public
- Asensus Surgical — Acquired
- Monogram Orthopedics — Public, $60M
- Surgerii Robotics — Series B, $100M
Frequently Asked Questions
- What companies are in the Surgical & Medical Robots category?
- The Surgical & Medical Robots category includes 15 companies: Intuitive Surgical, Medtronic (Hugo), Stryker (Mako), Zimmer Biomet (ROSA), CMR Surgical, Noah Medical, PROCEPT BioRobotics, THINK Surgical, Vicarious Surgical, ForSight Robotics, EndoQuest Robotics, Globus Medical, Asensus Surgical, Monogram Orthopedics, Surgerii Robotics. This is part of the Special Purpose Robotics market map maintained by Hartmann Capital.
- How many Surgical & Medical Robots startups are tracked?
- Hartmann Capital tracks 15 companies in the Surgical & Medical Robots segment of the Special Purpose Robotics market map.
- What are the best funded Surgical & Medical Robots companies?
- Top funded companies in Surgical & Medical Robots include CMR Surgical ($1000M), PROCEPT BioRobotics ($349M), THINK Surgical ($253M), ForSight Robotics ($195M), Noah Medical ($150M). Browse the full list in the Special Purpose Robotics market map.
- How can I submit my startup?
- You can submit your startup for inclusion by visiting the submission page. Submissions are reviewed by Hartmann Capital's research team.